Cargando…

Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats

Tissue protein hypercatabolism (TPH) is an important feature in cancer cachexia, particularly with regard to the skeletal muscle. The Yoshida AH-130 rat ascites hepatoma is a model system for studying the mechanisms involved in the processes that lead to tissue depletion, since it induces in the hos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carbó, N, López-Soriano, J, Costelli, P, Busquets, S, Alvarez, B, Baccino, F M, Quinn, L S, López-Soriano, F J, Argilés, J M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374658/ https://www.ncbi.nlm.nih.gov/pubmed/10945502 http://dx.doi.org/10.1054/bjoc.2000.1299

Ejemplares similares

Humoral mediation for cachexia in tumour-bearing rats.
por: Tessitore, L., et al.
Publicado: (1993)

Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?
por: Toledo, Míriam, et al.
Publicado: (2011)

Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance
por: Busquets, Sílvia, et al.
Publicado: (2011)

Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise
por: Penna, Fabio, et al.
Publicado: (2011)

Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)

TNF-α is involved in activating DNA fragmentation in skeletal muscle
por: Carbó, N, et al.
Publicado: (2002)

Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).
por: Dessì, S., et al.
Publicado: (1995)

Muscle Wasting and Impaired Myogenesis in Tumor Bearing Mice Are Prevented by ERK Inhibition
por: Penna, Fabio, et al.
Publicado: (2010)

Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3
por: Toledo, Míriam, et al.
Publicado: (2014)

Theophylline is able to partially revert cachexia in tumour-bearing rats
por: Olivan, Mireia, et al.
Publicado: (2012)

Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations
por: Pin, Fabrizio, et al.
Publicado: (2015)

Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia
por: Costelli, P, et al.
Publicado: (2001)

Nonmuscle Tissues Contribution to Cancer Cachexia
por: Argilés, Josep M., et al.
Publicado: (2015)

Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo
por: Hazama, S, et al.
Publicado: (1999)

Optimal management of cancer anorexia–cachexia syndrome
por: Argilés, Josep M, et al.
Publicado: (2010)

Therapeutic strategies against cancer cachexia
por: Argilés, Josep M., et al.
Publicado: (2019)

Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats
por: Salazar-Degracia, Anna, et al.
Publicado: (2017)

The cachexia score (CASCO): a new tool for staging cachectic cancer patients
por: Argilés, Josep M., et al.
Publicado: (2011)

Cachexia: a problem of energetic inefficiency
por: Argilés, Josep M., et al.
Publicado: (2014)

Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signalling
por: Dwarkasing, Jvalini T, et al.
Publicado: (2015)

Lack of Synergy Between β-Agonist Treatment and a Blockage of Sarcoplasmic Calcium Flow in a Rat Cancer Cachexia Model
por: Busquets, Silvia, et al.
Publicado: (2021)

Induction of Fos protein expression in spinal cord neurons of tumour-bearing rats
por: Kergozien, S, et al.
Publicado: (1999)

Formoterol in the treatment of experimental cancer cachexia: effects on heart function
por: Toledo, Míriam, et al.
Publicado: (2014)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

Alteration of tumour response to radiation by interleukin-2 gene transfer
por: Lee, J, et al.
Publicado: (2000)

Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET (A) receptor antagonism
por: Asham, E, et al.
Publicado: (2001)

Characterization of Glass Powder from Glass Recycling Process Waste and Preliminary Testing
por: Gimenez-Carbo, Ester, et al.
Publicado: (2021)

Interference with Ca(2+)-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia
por: Pin, Fabrizio, et al.
Publicado: (2017)

A multifactorial anti‐cachectic approach for cancer cachexia in a rat model undergoing chemotherapy
por: Toledo, Míriam, et al.
Publicado: (2015)

Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool
por: Argilés, Josep M., et al.
Publicado: (2017)

The animal cachexia score (ACASCO)
por: Betancourt, Angelica, et al.
Publicado: (2019)

Interleukin‐4 administration improves muscle function, adult myogenesis, and lifespan of colon carcinoma‐bearing mice
por: Costamagna, Domiziana, et al.
Publicado: (2020)

p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours
por: Le Frère-Belda, M A, et al.
Publicado: (2001)

Water-soluble aluminium phthalocyanine–polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice
por: Brasseur, N, et al.
Publicado: (1999)

Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
por: Springer, Jochen, et al.
Publicado: (2023)

Day–night pattern of energy expenditure and body temperature in cachectic tumour-bearing rats
por: Oudart, H, et al.
Publicado: (2000)

Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma
por: Matsumoto*, T, et al.
Publicado: (1999)

Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK(1) receptors
por: Palma, C, et al.
Publicado: (1999)

Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases
por: Quintieri, L, et al.
Publicado: (1999)

Interleukin-1 production by immunologically hyporeactive tumour-bearing mice.
por: Holán, V., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_gg8q3j0ki63095mbk6bhl2amuj